GSK Sues Moderna for Patent Infringement Over COVID, RSV Vaccines
Insurance Journal - Oct 15, 2024
British drugmaker GlaxoSmithKline sued Moderna in federal court in Delaware on Tuesday, accusing its American rival of violating GSK’s patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax. According to the two lawsuits, Moderna’s lipid nanoparti...
Recommended Articles
Posted: May 13, 2025
Mike McGavick is returning to the insurance world as a strategic advisor and board chairman of Mea P...
Posted: May 13, 2025
PJM Interconnection LLC, the largest US electric grid serving about 20% of Americans from the Midwes...
Posted: May 13, 2025
The Trump administration said on Monday it was convening an emergency task force and fast-tracking u...